The pharmacogenomics landscape is evolving from a niche scientific pursuit to a cornerstone of value-based healthcare,” said ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for ...

Launched less than three years ago, the system may be changing how point-of-care tests are used in doctor's offices and emergency rooms.

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...

Straits Research released its highly anticipated report, “Global Multiplex Testing Reagents Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 1.59 billion in ...

Antimicrobial resistance (AMR) remains a major global healthcare challenge, undermining the effectiveness of treatments for common infections and threatening modern medical advances. Improved ...

SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular ...

Co-Diagnostics, Inc. (NASDAQ:CODX) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing. The agreement aims ...

The "United States Drug Abuse Testing Market Trends & Forecast 2025" report has been added to ResearchAndMarkets.com's offering. The United States Drug Abuse Testing Market is expected to reach US$ ...